220 related articles for article (PubMed ID: 18384352)
1. Recombinant factor VIIa to prevent surgical bleeding in factor XI deficiency.
O'Connell NM; Riddell AF; Pascoe G; Perry DJ; Lee CA
Haemophilia; 2008 Jul; 14(4):775-81. PubMed ID: 18384352
[TBL] [Abstract][Full Text] [Related]
2. Monitoring low dose recombinant factor VIIa therapy in patients with severe factor XI deficiency undergoing surgery.
Riddell A; Abdul-Kadir R; Pollard D; Tuddenham E; Gomez K
Thromb Haemost; 2011 Sep; 106(3):521-7. PubMed ID: 21833443
[TBL] [Abstract][Full Text] [Related]
3. Lower doses of rFVIIa therapy are safe and effective for surgical interventions in patients with severe FXI deficiency and inhibitors.
Kenet G; Lubetsky A; Luboshitz J; Ravid B; Tamarin I; Varon D; Martinowitz U
Haemophilia; 2009 Sep; 15(5):1065-73. PubMed ID: 19486172
[TBL] [Abstract][Full Text] [Related]
4. Single Low Dose of rFVIIa Combined with Antifibrinolytic Agent is a Simple and Safe Treatment for Factor XI-Deficient Patients undergoing Surgery.
Salomon O; Budnik I; Avishai E; Tamarin I; Bashari D; Dardik R; Livnat T
Thromb Haemost; 2019 Dec; 119(12):1927-1932. PubMed ID: 31493780
[TBL] [Abstract][Full Text] [Related]
5. Recombinant activated factor VII and tranexamic acid are haemostatically effective during major surgery in factor XI-deficient patients with inhibitor antibodies.
Livnat T; Tamarin I; Mor Y; Winckler H; Horowitz Z; Korianski Y; Bar-Zakay B; Seligsohn U; Salomon O
Thromb Haemost; 2009 Sep; 102(3):487-92. PubMed ID: 19718468
[TBL] [Abstract][Full Text] [Related]
6. Successful use of recombinant factor VIIa in a patient with inhibitor secondary to severe factor XI deficiency.
Lawler P; White B; Pye S; Hermans C; Riddell A; Costello C; Brown S; Lee CA
Haemophilia; 2002 Mar; 8(2):145-8. PubMed ID: 11952851
[TBL] [Abstract][Full Text] [Related]
7. Ongoing risk of thrombosis with factor XI concentrate: 5 years experience in two centres.
Batty P; Honke A; Bowles L; Hart DP; Pasi KJ; Uprichard J; Austin SK
Haemophilia; 2015 Jul; 21(4):490-5. PubMed ID: 25855341
[TBL] [Abstract][Full Text] [Related]
8. Relationship between factor VII activity and clinical efficacy of recombinant factor VIIa given by continuous infusion to patients with factor VIII inhibitors.
Santagostino E; Morfini M; Rocino A; Baudo F; Scaraggi FA; Gringeri A
Thromb Haemost; 2001 Oct; 86(4):954-8. PubMed ID: 11686352
[TBL] [Abstract][Full Text] [Related]
9. Inhibitors to Factor XI in patients with severe Factor XI deficiency.
Salomon O; Zivelin A; Livnat T; Seligsohn U
Semin Hematol; 2006 Jan; 43(1 Suppl 1):S10-2. PubMed ID: 16427373
[TBL] [Abstract][Full Text] [Related]
10. The role of recombinant factor VIIa for obstetric block in women with severe factor XI deficiency.
Setty S; Reddell A; England A; Gomez K; Kadir R
Haemophilia; 2011 Nov; 17(6):906-9. PubMed ID: 21453421
[TBL] [Abstract][Full Text] [Related]
11. Factor XI replacement for inherited factor XI deficiency in routine clinical practice: results of the HEMOLEVEN prospective 3-year postmarketing study.
Bauduer F; de Raucourt E; Boyer-Neumann C; Trossaert M; Beurrier P; Faradji A; Peynet J; Borg JY; Chamouni P; Chatelanaz C; Henriet C; Bridey F; Goudemand J;
Haemophilia; 2015 Jul; 21(4):481-9. PubMed ID: 25817556
[TBL] [Abstract][Full Text] [Related]
12. Elective surgery in patients with congenital coagulopathies and inhibitors: experience of the National Haemophilia Centre of Venezuela.
Boadas A; Fernández-Palazzi F; De Bosch NB; Cedeño M; Ruiz-Sáez A
Haemophilia; 2011 May; 17(3):422-7. PubMed ID: 21118333
[TBL] [Abstract][Full Text] [Related]
13. The Management of Factor XI Deficiency in Pregnancy.
Davies J; Kadir R
Semin Thromb Hemost; 2016 Oct; 42(7):732-740. PubMed ID: 27699729
[TBL] [Abstract][Full Text] [Related]
14. Recombinant factor VIIa (NovoSeven) as a hemostatic agent after surgery for congenital heart disease.
Razon Y; Erez E; Vidne B; Birk E; Katz J; Tamari H; Dagan O
Paediatr Anaesth; 2005 Mar; 15(3):235-40. PubMed ID: 15725322
[TBL] [Abstract][Full Text] [Related]
15. Bleeding phenotype and correlation with factor XI (FXI) activity in congenital FXI deficiency: results of a retrospective study from a single centre.
Santoro C; Di Mauro R; Baldacci E; De Angelis F; Abbruzzese R; Barone F; Bochicchio RA; Ferrara G; Guarini A; Foà R; Mazzucconi MG
Haemophilia; 2015 Jul; 21(4):496-501. PubMed ID: 25623511
[TBL] [Abstract][Full Text] [Related]
16. Management of factor VII-deficient patients undergoing joint surgeries--preliminary results of locally developed treatment regimen.
Windyga J; Zbikowski P; Ambroziak P; Baran B; Kotela I; Stefanska-Windyga E
Haemophilia; 2013 Jan; 19(1):89-93. PubMed ID: 22845882
[TBL] [Abstract][Full Text] [Related]
17. Recombinant activated factor VIIa in uncontrolled bleeding: a haemostasis laboratory study in non-haemophilia patients.
Brandsborg S; Sørensen B; Poulsen LH; Ingerslev J
Blood Coagul Fibrinolysis; 2006 Jun; 17(4):241-9. PubMed ID: 16651865
[TBL] [Abstract][Full Text] [Related]
18. Safety and efficacy of factor XI (FXI) concentrate use in patients with FXI deficiency: a single-centre experience of 19 years.
Ling G; Kagdi H; Subel B; Chowdary P; Gomez K
Haemophilia; 2016 May; 22(3):411-8. PubMed ID: 26663472
[TBL] [Abstract][Full Text] [Related]
19. Recombinant factor VIIa for the prevention and treatment of bleeding in patients without haemophilia.
Lin Y; Stanworth S; Birchall J; Doree C; Hyde C
Cochrane Database Syst Rev; 2011 Feb; (2):CD005011. PubMed ID: 21328270
[TBL] [Abstract][Full Text] [Related]
20. Surgery in patients with haemophilia and high responding inhibitors: Izmir experience.
Balkan C; Karapinar D; Aydogdu S; Ozcan C; Ay Y; Akin M; Kavakli K
Haemophilia; 2010 Nov; 16(6):902-9. PubMed ID: 20518817
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]